Greenwich LifeSciences (GLSI) Institutional Ownership $8.95 -0.33 (-3.56%) Closing price 04/15/2025 04:00 PM EasternExtended Trading$8.95 0.00 (0.00%) As of 08:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Greenwich LifeSciences (NASDAQ:GLSI)CurrentInstitutional OwnershipPercentage4.16%Number ofInstitutional Buyers(last 12 months)13TotalInstitutional Inflows(last 12 months)$1.55MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$138.78K Get GLSI Insider Trade Alerts Want to know when executives and insiders are buying or selling Greenwich LifeSciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data GLSI Institutional Buying and Selling by Quarter Remove Ads Greenwich LifeSciences Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails4/8/2025 Rhumbline Advisers9,673$92K0.0%+48.7%0.074% 4/7/2025 GAMMA Investing LLC1,202$126K0.0%N/A0.009% 2/17/2025Bank of America Corp DE7,262$82K0.0%+22.3%0.055% 2/14/2025Northern Trust Corp87,423$982K0.0%+17.3%0.665% 2/13/2025Barclays PLC9,648$108K0.0%+12.7%0.073% 2/13/2025Renaissance Technologies LLC22,700$255K0.0%-30.2%0.173% 2/13/2025Wells Fargo & Company MN2,847$32K0.0%+54.8%0.022% 2/12/2025Brown Brothers Harriman & Co.4,000$45K0.0%N/A0.030% 2/12/2025JPMorgan Chase & Co.7,061$79K0.0%+172.0%0.054% 12/10/2024Garden State Investment Advisory Services LLC17,600$253K0.1%N/A0.134% Get the Latest News and Ratings for GLSI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Greenwich LifeSciences and its competitors with MarketBeat's FREE daily newsletter. 11/19/2024Barclays PLC8,560$123K0.0%+323.3%0.065% 11/16/2024Geode Capital Management LLC133,550$1.92M0.0%+4.6%1.016% 11/15/2024Barclays PLC8,560$123K0.0%+323.3%0.065% 11/15/2024State Street Corp71,408$1.03M0.0%+4.4%0.543% 11/15/2024Garden State Investment Advisory Services LLC17,600$253K0.1%N/A0.134% 11/12/2024Charles Schwab Investment Management Inc.16,455$236K0.0%-10.8%0.125% 8/1/2024 Rhumbline Advisers6,799$117K0.0%N/A0.053% 7/26/2024Bank of New York Mellon Corp15,295$264K0.0%N/A0.119% 5/10/2024Vanguard Group Inc.223,102$4.45M0.0%+0.6%1.732% 2/14/2023683 Capital Management LLC11,700$178K0.0%N/A0.091% 11/15/2022Pura Vida Investments LLC19,667$179K0.0%N/A0.153% 8/8/2022Walleye Capital LLC10,656$90K0.0%N/A0.082% 4/29/2022Nisa Investment Advisors LLC7,200$141K0.0%N/A0.056% 2/7/2022SG Americas Securities LLC4,395$107K0.0%N/A0.034% 11/15/2021Invesco Ltd.148,087$5.79M0.0%-47.1%1.138% 11/15/2021Tibra Equities Europe Ltd12,700$496K0.8%N/A0.098% 11/12/2021OLD Mission Capital LLC7,358$287K0.0%N/A0.057% 11/12/2021Geode Capital Management LLC56,919$2.22M0.0%+8.6%0.437% 8/17/2021Invesco Ltd.280,062$12.59M0.0%N/A2.171% 8/16/2021California State Teachers Retirement System5,588$251K0.0%N/A0.043% 8/16/2021Charles Schwab Investment Management Inc.9,819$442K0.0%N/A0.076% 8/16/2021State Street Corp50,212$2.26M0.0%N/A0.389% 8/16/2021Nuveen Asset Management LLC6,392$287K0.0%N/A0.050% 8/13/2021Northern Trust Corp12,098$544K0.0%N/A0.094% 8/13/2021Geode Capital Management LLC52,395$2.35M0.0%+262.3%0.406% 8/13/2021Vanguard Group Inc.121,418$5.46M0.0%+14.3%0.941% 8/12/2021State of Wisconsin Investment Board5,200$234K0.0%N/A0.040% 8/12/2021JPMorgan Chase & Co.4,789$216K0.0%N/A0.037% 8/11/2021Bank of New York Mellon Corp6,664$300K0.0%N/A0.052% 8/11/2021BlackRock Inc.217,748$9.79M0.0%+242.7%1.688% Elon’s Silver Play? Trump Clears the Path (Ad)Nothing is confirmed—yet. But Musk has disrupted every industry he's touched, and Trump's policies make the timing perfect. Silver surged 23% in 2024. If Musk moves into silver, prices could explode—and those waiting on the sidelines will be left scrambling.This guide is your blueprint for understanding silver's untapped potential, the forces driving its d8/11/2021Deutsche Bank AG2,396$108K0.0%N/A0.019% 8/10/2021Citigroup Inc.1,611$72K0.0%+212.8%0.012% 8/2/2021New York State Common Retirement Fund3,500$157K0.0%N/A0.027% 5/18/2021Millennium Management LLC19,450$663K0.0%+169.7%0.000% 5/18/2021Citadel Advisors LLC7,114$243K0.0%N/A0.000% 5/17/2021Royal Bank of Canada2,800$95K0.0%N/A0.000% 5/17/2021HRT Financial LP10,952$373K0.0%N/A0.000% 5/12/2021Geode Capital Management LLC14,463$493K0.0%+106.0%0.000% 5/7/2021BlackRock Inc.63,540$2.17M0.0%+7.2%0.000% 4/30/2021Creative Planning7,351$251K0.0%+4.4%0.000% 4/29/2021SkyOak Wealth LLC7,405$293K0.1%-8.6%0.000% 2/9/2021Wells Fargo & Company MN1,134$41K0.0%N/A0.000% (Data available from 1/1/2016 forward)Remove Ads GLSI Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of GLSI shares? During the previous two years, 15 institutional investors and hedge funds held shares of Greenwich LifeSciences. The most heavily invested institutionals were Vanguard Group Inc. ($4.45M), Geode Capital Management LLC ($1.92M), State Street Corp ($1.03M), Northern Trust Corp ($982K), Bank of New York Mellon Corp ($264K), Renaissance Technologies LLC ($255K), and Garden State Investment Advisory Services LLC ($253K).Learn more on GLSI's institutional investors. What percentage of Greenwich LifeSciences stock is owned by institutional investors? 4.16% of Greenwich LifeSciences stock is owned by institutional investors. Learn more on GLSI's institutional investor holdings. Which institutional investors have been buying Greenwich LifeSciences stock? Of the 13 institutional investors that purchased Greenwich LifeSciences stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Garden State Investment Advisory Services LLC ($35.20K), Bank of New York Mellon Corp ($15.30K), Barclays PLC ($14.16K), Northern Trust Corp ($12.92K), Rhumbline Advisers ($9.97K), Geode Capital Management LLC ($5.86K), and JPMorgan Chase & Co. ($4.47K). How much institutional buying is happening at Greenwich LifeSciences? Institutional investors have bought a total of 109,832 shares in the last 24 months. This purchase volume represents approximately $1.55M in transactions. Which Greenwich LifeSciences major shareholders have been selling company stock? The following institutional investors have sold Greenwich LifeSciences stock in the last 24 months: Renaissance Technologies LLC ($9.80K), and Charles Schwab Investment Management Inc. ($2.00K). How much institutional selling is happening at Greenwich LifeSciences? Institutional investors have sold a total of 11,799 shares in the last 24 months. This volume of shares sold represents approximately $138.78K in transactions. Related Companies DNTH Institutional Ownership ORGO Institutional Ownership GHRS Institutional Ownership ALMS Institutional Ownership QURE Institutional Ownership BCYC Institutional Ownership KURA Institutional Ownership URGN Institutional Ownership MGTX Institutional Ownership IMTX Institutional Ownership This page (NASDAQ:GLSI) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Greenwich LifeSciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Greenwich LifeSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.